P21-activated kinases (PAKs) are novel therapeutic targets in human breast cancer

被引：0
|
作者：
Ong, Christy [1 ]
Jubb, Adrian [1 ]
Haverty, Peter [1 ]
Zhou, Wei [1 ]
Lyle, Karen [1 ]
Harris, Adrian [2 ]
Belvin, Marcia [1 ]
Friedman, Lori [1 ]
Koeppen, Hartmut [1 ]
Hoeflich, Klaus P. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Univ Oxford, Oxford, England
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4004
引用
收藏
页数：2
相关论文
共 50 条
  • [21] p21-activated kinases and gastrointestinal cancer
    He, Hong
    Baldwin, Graham S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2013, 1833 (01): : 33 - 39
  • [22] P21-ACTIVATED KINASES AND BLADDER CANCER
    Ismail, Ahmad Fahim
    Dasgupta, Prokar
    Wells, Claire
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A19 - A19
  • [23] Functions of the p21-activated protein kinases (Paks) in neutrophils and their regulation by complex lipids
    Robinson, D
    Huang, RY
    Lian, JP
    Toker, A
    Badwey, JA
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, IMFLAMMATION AND RADIATION INJURY, 4, 1999, 469 : 385 - 390
  • [24] Emerging functions of p21-activated kinases in human cancer cells
    Kumar, R
    Vadlamudi, RK
    JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 193 (02) : 133 - 144
  • [25] Communication - a novel regulator of p21-activated kinases
    Bagrodia, Shubha
    Taylor, Stephen J.
    Jordon, K. Antonia
    Van Aelst, Linda
    Cerione, Richard A.
    Journal of Biological Chemistry, 1998, 273 (37):
  • [26] The Role of p21-Activated Kinases in Pancreatic Cancer
    Yeo, Dannel
    He, Hong
    Baldwin, Graham S.
    Nikfarjam, Mehrdad
    PANCREAS, 2015, 44 (03) : 363 - 369
  • [27] Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer
    Yi, Chunling
    Maksimoska, Jasna
    Marmorstein, Ronen
    Kissil, Joseph L.
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 683 - 689
  • [28] Biology of the p21-activated kinases
    Bokoch, GM
    ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 : 743 - 781
  • [29] Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type
    Yi, Chunling
    Wilker, Erik W.
    Yaffe, Michael B.
    Stemmer-Rachamimov, Anat
    Kissil, Joseph L.
    CANCER RESEARCH, 2008, 68 (19) : 7932 - 7937
  • [30] p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma
    Qasim, Shawki L.
    Sierra, Laura
    Shuck, Ryan
    Kurenbekova, Lyazat
    Patel, Tajhal D.
    Rajapakshe, Kimal
    Wulff, Jade
    Nakahata, Kengo
    Kim, Ha Ram
    Landesman, Yosef
    Unger, T. J.
    Coarfa, Cristian
    Yustein, Jason T.
    ONCOGENE, 2021, 40 (06) : 1176 - 1190
12345